Stem Holdings, Inc.
STMHDelisted- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001697834
Stem Holdings, Inc. was delisted in 2024; its insiders filed their last Form 4 on Sep 8, 2023; no institution reported holding it in 13F filings for Q4 2023; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Stem Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Stem Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Rai Rajiv | Director | 7,494,853 | Sep 8, 2023 | 0 |
| Cohen Matthew | CEO, CFO, Treasurer & Sec. | 11,359,961 | Apr 6, 2023 | 0 |
| Suskind Dennis | Director | 450,000 | Oct 22, 2021 | 0 |
| Snider Lindy L | Director | 159,044 | Oct 22, 2021 | 0 |
| Hubbard Steven Shelly | Secretary | 853,007 | Sep 10, 2021 | 0 |
| Berk Adam | Chief Executive Officer | 7,448,174 | Sep 10, 2021 | 0 |
| Bender Garrett Martin | Director | 5,631,887 | Sep 3, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.